BIOATLA, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOATLA, INC. stock issued during period, value, new issues for the quarter ending 2021-12-31 was -$60.00K.
- BIOATLA, INC. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $71.05M.
- BIOATLA, INC. stock issued during period, value, new issues for fiscal 2022 was $61.68M, a 13.12% decline from fiscal 2021.
- BIOATLA, INC. stock issued during period, value, new issues for fiscal 2021 was $70.99M, a 64.20% decline from fiscal 2020.
- BIOATLA, INC. stock issued during period, value, new issues for fiscal 2020 was $198.32M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2022-12-31 | $61.68M 10-K · filed 2024-03-26 | |
| 2021-12-31 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $70.99M 10-K · filed 2023-03-23 |
| 2021-09-30 | $71.05M 10-Q · filed 2022-11-04 | |
| 2020-12-31 | $198.32M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |